AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of AbbVie Inc. (ABBV) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on Feb 18, 2022.
The trade happened on Jan 28, 2022, 21 days before it was made public.
ABBV has moved +90.6% since the trade date, from $137.92 to $262.90 (Oct 2, 2026 close).
- Traded
- Jan 28, 2022
- Disclosed
- Feb 18, 2022
- Filing delay
- 21 days
- Price since
- +90.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (32)
- BuyMSFT$50K-$100KFeb 18, 2022
- SellALGN$1K-$15KFeb 18, 2022
- SellAMD$1K-$15KFeb 18, 2022
- SellAMD$1K-$15KFeb 18, 2022
- SellASML$1K-$15KFeb 18, 2022
- SellBEN$1K-$15KFeb 18, 2022
- SellBEN$1K-$15KFeb 18, 2022
- BuyBIIB$1K-$15KFeb 18, 2022
- SellBOOT$1K-$15KFeb 18, 2022
- BuyCOF$1K-$15KFeb 18, 2022
- SellEL$1K-$15KFeb 18, 2022
- SellFCX$1K-$15KFeb 18, 2022
- BuyFIS$1K-$15KFeb 18, 2022
- BuyFIS$1K-$15KFeb 18, 2022
- BuyHQY$1K-$15KFeb 18, 2022
- SellISRG$1K-$15KFeb 18, 2022
- BuyKO$1K-$15KFeb 18, 2022
- SellLRCX$1K-$15KFeb 18, 2022
- SellMTCH$1K-$15KFeb 18, 2022
- SellNFLX$1K-$15KFeb 18, 2022
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.